Back to Test Catalogue

Inhibin A, Serum

Test ID: INHIBA S

Test

Method

Immunoassay (IA)

Platform

Beckman-Coulter CLIA

Report Includes

Inhibin A

Specimens

Serum

Clinical Utility

Inhibin A is useful as an indicator of gonadal function, and ovarian response to hMg or to FSH stimulation. Inhibin A, produced by the placenta, is used along with other maternal serum biochemical markers to improve sensitivity of the screen for Down Syndrome risk.
This test was performed using the Beckman-Coulter Chemiluminescent Inhibin-A method that has been cleared by the FDA strictly for in vitro use as an aid in the diagnosis and monitoring of various hormonal reproductive disorders. The Inhibin-A test should not be used as a diagnostic procedure for granulosa cell tumors or hydatidiform moles without confirmation of the diagnosis by another established product or procedure. Values obtained with different assay methods or kits cannot be used interchangeably.

Test Location

Quest Diagnostics, California USA

Test Version

1-Nov-2022

Specimen

Specimens

Serum

Collection Containers

Gold top (clot activator & gel)

Sample Volume

2.0 ml

Minimum Volume

0.5 ml

Collection & Handling

Collection Instructions

When ordered with Inhibin B, Serum, a separate aliquot must be submitted.

Stability

Ambient 14 days
Refrigerated 14 days
Frozen 28 days

Rejection Criteria

Hemolysis Gross
Lipemia Gross

Test Version

1-Nov-2022

Performance / Interpretation

Method

Immunoassay (IA)

Platform

Beckman-Coulter CLIA

Turnaround Time

8 days

Results

Name Units Reference Range Conversion Factor
Inhibin A pg/mL
  • Male: <2.0
  • Female:
  • Premenopausal: < 98.0
  • Postmenopausal: < 2.1
This test was performed using the Beckman-Coulter Chemiluminescent Inhibin-A method that has been cleared by the FDA strictly for in vitro use as an aid in the diagnosis and monitoring of various hormonal reproductive disorders. The Inhibin-A test should not be used as a diagnostic procedure for granulosa cell tumors or hydatidiform moles without confirmation of the diagnosis by another established product or procedure. Values obtained with different assay methods or kits cannot be used interchangeably.

Test Location

Quest Diagnostics, California USA

Test Version

1-Nov-2022

Interface / Setup

HL7 Interface Codes

Order Code Result Codes Units
INHIBA S 64095INHIBIN A pg/mL

Test Version

1-Nov-2022